Cite
Chio LF, Oon CJ. Changes in serum alpha 1 antitrypsin, alpha1 acid glycoprotein and beta 2 glycoprotein I in patients with malignant hepatocellular carcinoma. Cancer. 1979;43(2):596-604doi: 10.1002/1097-0142(197902)43:2<596::aid-cncr2820430229>3.0.co;2-r.
Chio, L. F., & Oon, C. J. (1979). Changes in serum alpha 1 antitrypsin, alpha1 acid glycoprotein and beta 2 glycoprotein I in patients with malignant hepatocellular carcinoma. Cancer, 43(2), 596-604. https://doi.org/10.1002/1097-0142(197902)43:2<596::aid-cncr2820430229>3.0.co;2-r
Chio, L F, and Oon, C J. "Changes in serum alpha 1 antitrypsin, alpha1 acid glycoprotein and beta 2 glycoprotein I in patients with malignant hepatocellular carcinoma." Cancer vol. 43,2 (1979): 596-604. doi: https://doi.org/10.1002/1097-0142(197902)43:2<596::aid-cncr2820430229>3.0.co;2-r
Chio LF, Oon CJ. Changes in serum alpha 1 antitrypsin, alpha1 acid glycoprotein and beta 2 glycoprotein I in patients with malignant hepatocellular carcinoma. Cancer. 1979 Feb;43(2):596-604. doi: 10.1002/1097-0142(197902)43:2<596::aid-cncr2820430229>3.0.co;2-r. PMID: 84707.
Copy
Download .nbib